GORMAN KEVIN CHARLES

NBIX

GORMAN KEVIN CHARLES serves as Director at Neurocrine Biosciences, Inc. (NBIX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.0K

Total Sells

17 trades

$71.88M

Net Position

Net Seller

$71.88M

Companies Traded

NBIX, XNCR

Active Period

Feb 2022 – Feb 2026

18 total trades

Most Recent

Sell NBIX

Feb 17, 2026 · $5.00M

GORMAN KEVIN CHARLES's Insider Trading at Neurocrine Biosciences, Inc. (NBIX)

Buys

0 · $0.00

Sells

15 · $71.80M

Total Shares Bought

Total Shares Sold

543,944

NBIX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 17, 2026	Sell	40,305	$124.12	$5.00M	0
Aug 11, 2025	Sell	106,322	$126.41	$13.44M	514,596
May 29, 2025	Sell	9,613	$120.38	$1.16M	514,596
Feb 14, 2025	Sell	5,844	$116.69	$681.9K	524,209
Feb 12, 2025	Sell	2,274	$118.37	$269.2K	519,074
Feb 4, 2025	Sell	2,707	$152.92	$414.0K	517,030
Jan 29, 2025	Sell	146,105	$149.46	$21.84M	514,596
Feb 15, 2024	Sell	2,832	$133.02	$376.7K	514,596
Feb 8, 2024	Sell	5,314	$138.74	$737.3K	506,962
Feb 2, 2024	Sell	2,707	$140.69	$380.8K	502,188
Jan 10, 2024	Sell	167,858	$133.02	$22.33M	499,754
Aug 23, 2023	Sell	9,328	$107.40	$1.00M	499,754
Feb 8, 2023	Sell	29,044	$102.90	$2.99M	491,365
Feb 2, 2023	Sell	2,707	$110.08	$298.0K	465,278
Feb 9, 2022	Sell	10,984	$80.54	$884.7K	462,844